Ad is loading...
MENU

ALLO Allogene Therapeutics Forecast, Technical & Fundamental Analysis

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALLO is expected to report earnings to rise 2.34% to -32 cents per share on February 26

Allogene Therapeutics ALLO Stock Earnings Reports
Q4'24
Est.
$-0.33
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.35
Q1'24
Beat
by $0.03
Q4'23
Missed
by $0.06
The last earnings report on November 07 showed earnings per share of -31 cents, beating the estimate of -33 cents. With 3.09M shares outstanding, the current market capitalization sits at 475.96M.
A.I. Advisor
published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
210 East Grand Avenue
Phone
+1 650 457-2700
Employees
233
Web
https://www.allogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWIIX14.34N/A
N/A
Redwood AlphaFactor Tactical Intl I
TRLCX23.69-0.06
-0.25%
Nuveen Large Cap Value Retire
HDVIX12.35-0.07
-0.56%
Hartford International Equity I
SRIAX14.15-0.08
-0.56%
Gabelli SRI A
CLSPX31.02-0.54
-1.71%
Columbia Select Mid Cap Gro Fd I

ALLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-7.72%
FATE - ALLO
58%
Loosely correlated
-2.88%
NTLA - ALLO
56%
Loosely correlated
-7.61%
BEAM - ALLO
55%
Loosely correlated
-8.59%
CRSP - ALLO
54%
Loosely correlated
+0.85%
CRBU - ALLO
54%
Loosely correlated
-4.78%
More